It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2017.
2017 | Mumbai, Maharashtra, India | ActiveBarak Pharmaceutical Private Limited, a active private limited company, was established on 27 October 2017 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999MH2017PTC301240. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Dinesh Sahadevrao Sahare (Director), Nisha Sahare Dinesh (Director). Past directors included Vishal Namdevrao Ambade, Ritesh Sahadeorao Sahare. It holds ₹0.50 M open charges and no settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at B-104-3/3, Floor-Grd, Nity Anand Nagar, Dr Babasaheb Ambedkar Road, Matunga, Mumbai, Maharashtra, 400019.
U74999MH2017PTC301240
301240
27 October 2017
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Barak Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dinesh Sahadevrao Sahare | Director | 27 Oct 2017 | Current |
| Nisha Sahare Dinesh | Director | 17 Jun 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jul 2019 | Past |
| Pramod Abcsdd | Director | 20 Feb 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Barak Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 90.05% decrease. The company also saw a substantial fall in profitability, with a 91.66% decrease in profit. The company's net worth moved up by a moderate rise of 2.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Barak Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Mar 2019 | Others | ₹0.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Barak Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Barak Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Barak Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Barak Pharmaceutical Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was completed.
Barak Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was recorded as a recent event.
The activity Nisha Sahare Dinesh was appointed as a Director was appointed as a Director on 17 Jun 2019 & has been associated with this company since 6 years 6 months . was completed.
A charge with Others of Rs. 0.50 M registered on 20 Mar 2019 with Charge ID 100253997 was modified on 20 May 2019. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.50 M with Charge ID 100253997 was registered on 20 Mar 2019. was completed.
Progress on Dinesh Sahadevrao Sahare was appointed as a Director was appointed as a Director on 27 Oct 2017 & has been associated with this company since 8 years 1 month . was documented.
The CIN of Barak Pharmaceutical Private Limited is U74999MH2017PTC301240.
Barak Pharmaceutical Private Limited is headquartered at B-104-3/3, Floor-Grd, Nity Anand Nagar, Dr Babasaheb Ambedkar Road, Matunga, Mumbai, Maharashtra, 400019.
Barak Pharmaceutical Private Limited was incorporated on 27 October 2017.
The current directors of Barak Pharmaceutical Private Limited are
The primary industry of Barak Pharmaceutical Private Limited is Trade.
Barak Pharmaceutical Private Limited is unlisted.
The authorized capital of Barak Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Barak Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX